RACHAEL SCHNEIDER: Open Payments
NPI 1053593442 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 27 payments from 14 companies in 2025. Trend: 2023 $3,958 · 2024 $6,042 · 2025 $1,219
Food & beverage: $1,219
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $275 |
| Impulse Dynamics (USA) Inc. | 2 | $198 |
| E.R. Squibb & Sons, L.L.C. | 3 | $165 |
| Abbott Laboratories | 4 | $140 |
| PFIZER INC. | 5 | $125 |
| BridgeBio Pharma, Inc. | 3 | $88 |
| ABIOMED | 1 | $59 |
| Boston Scientific Corporation | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: Rapiblyk, Optimizer, CAMZYOS, ELIQUIS, AVEIR, Attruby, VYNDAQEL, MERLIN@HOME.
Industry payments across TX — which companies pay providers there.
